Reference
Marini C, et al. Tolerability and Efficacy of Treatment With Azacytidine as Prophylactic or Preemptive Therapy for Myeloid Neoplasms After Allogeneic Stem Cell Transplantation. Clinical Lymphoma, Myeloma & Leukemia 20: 377-382, No. 6, Jun 2020. Available from: URL: http://doi.org/10.1016/j.clml.2019.10.011
Rights and permissions
About this article
Cite this article
Azacitidine. Reactions Weekly 1812, 50 (2020). https://doi.org/10.1007/s40278-020-80529-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-80529-9